| Document |
Document Title |
|
WO/2023/179884A1 |
Suggested is the use of at least one fragrance having a molecular weight between 95 to 225 g/mol as a urease inhibitor.
|
|
WO/2023/176501A1 |
A biocompatible member according to an embodiment of the present invention has multiple fibers containing a biocompatible material. The adjacent fibers are covalently bonded to each other at multiple places in the direction in which the ...
|
|
WO/2023/172751A1 |
Device and methods for treating wounds or surgical sites are provided. The devices and methods include use of antifibrinolytic agents such as tranexamic acid to reduce exudate and improve wound healing. Embodiments provide for the timed ...
|
|
WO/2023/173063A2 |
Provided are reusable face masks comprising a single piece mask body configured to cover a nose and a mouth of a human face and comprising at least one filter attachment port, wherein the at least one filter attachment port comprises a c...
|
|
WO/2023/169647A1 |
A sanitary article, such as a sanitary pad, a pantyliner, a pant diaper or an open diaper, according to the present disclosure comprises a fluid permeable topsheet and a backsheet. The sanitary article extends in a longitudinal direction...
|
|
WO/2023/168616A1 |
An absorbent article (20), such as a diaper, comprising a liquid-permeable topsheet (24), an upper acquisition-distribution system (52, 54), an absorbent core (28) comprising a layer of superabsorbent polymer particles (60) disposed in a...
|
|
WO/2023/170558A1 |
The present invention relates to a method for preparing a system for controlled release of antibiotics and bioactive factors, which is formed by microspheres in a hydrogel, wherein the method comprises synthesising W1/O/W2 microspheres t...
|
|
WO/2023/170148A1 |
The present invention relates to biodegradable, non-porous medical devices and particular to such devices comprising a sheet-like structural layer and a multi- layered water-activatable adhesive component. The invention further relates t...
|
|
WO/2023/160772A1 |
The present invention relates to a skin dressing for topical delivery of an active agent, such as nitric oxide, comprising a covering layer, an absorbent layer, a first compartment comprising a first reactant, wherein the first reactant ...
|
|
WO/2023/161828A1 |
Described herein are compositions of EDTA having activity against planktonic and biofilm cells of clinically relevant pathogens. The compositions generally include EDTA and are capable of inhibiting the growth and proliferation of microb...
|
|
WO/2023/164086A1 |
An antimicrobial prosthetic liner having an exterior fabric layer and an inner layer comprising a thermoplatic and further incorporating evenly distributed nanoparticles of certain metal oxide nanoparticles in an amount ranging from 2 %-...
|
|
WO/2023/164113A1 |
Surgical stapling devices have a surgical buttress attached to an anvil jaw member, a cartridge jaw member, or both. In use, the surgical buttress reinforces a staple line formed upon application of staples from the surgical stapling dev...
|
|
WO/2023/156851A1 |
The present invention relates to a synthesis method of a series of new biodegradable, hydrophilic materials in the form of a film and prepared from a semi-impenetrable network (semi-IPN) of poly(3-hydroxybutyrate-co-3-valerate) and cross...
|
|
WO/2023/156749A1 |
The invention relates to a polymerisable composition for use as an adhesive for biological tissue, in particular for non-mineralised biological tissue, comprising an acrylate-type polymerisable monomer, a photoinitiator and a photopolyme...
|
|
WO/2023/154736A1 |
Some tissue adhesives include a solid having bio-absorbable fibers and at least one of nano-spheres, micro-spheres, nano-tubules, or micro-tubules. A first layer of the solid has a positive Poisson's ratio and a second layer of the solid...
|
|
WO/2023/149728A1 |
The present invention relates to a biodegradable resin composition and a medical splint comprising same. The biodegradable resin composition may comprise: a compatibilizer including polylactide (PLA-g-GMA) grafted using polylactide (PLA)...
|
|
WO/2023/144301A1 |
The present invention relates to the use of neutral core human milk oligosaccharides such as in particular lacto-N-(neo)tetraoses as anti-ageing active ingredient as well as the use thereof in topical anti-ageing compositions.
|
|
WO/2023/140719A1 |
An aspect relates to a microfluidic device and use thereof. The microfluidic device of the present invention comprises one or more micro-pillars therein, and thus, when blood flow forms inside the device, shear stress is generated by the...
|
|
WO/2023/137605A1 |
A medical grade silicone gel sheet designed with pressure technology for treatment of post surgery hypertrophic scars. The silicone gel sheet is consisted of a silicone gel layer (1), a silicone rubber fixing layer (2,3) with the designs...
|
|
WO/2023/136817A1 |
Described are systems, devices, and methods useful in the prevention and/or detection of liquid intrusion into ultrasound equipment. Ultrasound transducers and associated ultrasound circuitry, which can be located in an interior of an ul...
|
|
WO/2023/134899A1 |
The invention relates to thermoresponsive wound dressings having thermally switchable adhesion/de-adhesion, comprising: a carrier material and an adhesive composition applied to a surface of the carrier material, wherein the adhesive com...
|
|
WO/2023/135469A1 |
Wound care coverings include a pad comprising a pad material, a lactate-based enzyme crosslinked with the pad material by a crosslinker, and a dye that changes color when H2O2 is present. In examples, an enzyme layer comprises a pad mate...
|
|
WO/2023/133142A1 |
A silica gel foam dressing includes a gluing carrier layer, a liquid absorption layer and a wound contact layer, wherein the liquid absorption layer is arranged between the gluing carrier layer and the wound contact layer, the wound cont...
|
|
WO/2023/130265A1 |
Composition of a surface microstructure (2) of a wound dressing (1). The main body is a dressing (1), comprising a non-woven polymer base material, the surface of which comprises a microstructure (2) formed by stacking at least one metal...
|
|
WO/2023/126839A1 |
The disclosed sealing film is for surrounding a device for tamper evident protection of the contained device. The sealing film has a backing with a perimeter surrounding a central area and an adhesive on the backing at least at the perim...
|
|
WO/2023/123879A1 |
The present invention relates to the technical field of medical dressings, in particular to an antibacterial polyurethane sponge and a preparation method therefor. An antibacterial dressing, which is obtained by means of adding an antiba...
|
|
WO/2023/118966A1 |
The present disclosure relates to biomaterials derived from sustainable sources. Described herein are biomaterials and tissue engineering constructs comprising components derived from sustainable sources such as from tunicates, fish skin...
|
|
WO/2023/118599A1 |
[000509] The invention concerns an implantable device comprising at least a hydrogel which may incorporate: - active principles, such as peptides, hormones or proteins, or - secreting cells, which may be cells secreting peptides or hormo...
|
|
WO/2023/117354A1 |
The present disclosure generally relates to a polyurethane foam use as a wound pad (101, 201) or wound pad layer (201a-c), wherein the polyurethane foam comprises an antimicrobial salt. The present disclosure also relates to a wound pad ...
|
|
WO/2023/119265A1 |
The invention relates to compositions comprised of albumin and clottable proteins including fibrinogen and to use thereof e.g., for treating bleeding. In particular, the compositions are comprised of albumin and one or more clottable pro...
|
|
WO/2023/111959A1 |
An article and a method of making the article. The article can include a conformable matrix comprising a mixture of collagen, bioactive glass, and an additive selected from cellulose and/or alginate; wherein the article is a conformable ...
|
|
WO/2023/114561A1 |
A bacteria-responsive shape memory polymer (SMP) platform with clinical impact for chronic wound infection control. A bacteria-responsive SMP is synthesized in a primary shape and then fixed in a secondary shape until exposed to a second...
|
|
WO/2023/114425A1 |
Compositions that contain a substrate and silver particles are provided, where the composition are anhydrous, optionally having antimicrobial properties in either the anhydrous or a rehydrated form.
|
|
WO/2023/113783A1 |
Absorbent articles with low void volumes and fast fluid intake properties are described. In one embodiment, an absorbent article has a liner, backsheet, and absorbent structure disposed therebetween. The absorbent structure may comprise ...
|
|
WO/2023/111197A1 |
Use of a textile article containing graphene to produce a bandage to be applied on wounds, wherein said graphene comprises graphene nano-platelets in which at least 90% has a lateral dimension (x, y) from 500 to 50000 nm and a thickness ...
|
|
WO/2023/111353A1 |
The present invention relates to a composition comprising a biomaterial-based porous material coated with a powder and a method of making such compositions The invention further relates to a method of controlling bleeding and/or leakage ...
|
|
WO/2023/107344A1 |
A negative pressure dressing assembly includes a drape including an aperture, a cover assembly selectively sealing the aperture in an air-tight manner, a reactor configured to react with a selected gas, and a sealing liner that forms a b...
|
|
WO/2023/105508A1 |
Problem to be solved: To provide a composition for wet indicator excellent in discoloration performance and compatibility, and having suppressed odor. Means for solution: A composition for wet indicator comprising an oily gel containing ...
|
|
WO/2023/106513A1 |
The present invention relates to a bio-patch-type cell therapy product for skin regeneration, comprising placenta-derived stem cells, and has the benefit of being able to be conveniently used as a bio-transplant material, without contami...
|
|
WO/2023/102845A1 |
A cascaded material surface active catalytic structure, mainly formed by combining a polymer base material (1) and a negative dielectric material layer (2) provided on the surface of the polymer base material (1). The polymer base materi...
|
|
WO/2023/106112A1 |
The present invention provides: an indicator for an absorbent article that does not readily dissolve in moisture such as urine or dampness, said indicator enabling any change in the urine specific gravity to be accurately sensed; and an ...
|
|
WO/2023/101569A1 |
The subject of the invention is a method of obtaining an antimicrobially active nonwoven fabric, which is prepared in an aqueous solution containing: • from 0.1 to 30 wt% citric acid, • from 0.1 to 20 wt% chitosan, • from 0.1 to 15...
|
|
WO/2023/100501A1 |
One embodiment pertains to an adhesive for skin affixation containing (A) a polymer having a reactive functional group, (B) a urethane compound in which the mass average molecular weight is 1,500-40,000, and (C) a curing agent, the ureth...
|
|
WO/2023/094179A1 |
The present invention relates to an electret-based wound dressing comprising a laminate, constituted of two films that consist of expanded sintered PTFE having a thickness in the range of 0.3 to 1 mm. An aluminum foil having a thickness ...
|
|
WO/2023/097097A1 |
A reversibly adhesive film, comprising: at least two hydroxyl-bearing polymer chains being crosslinked by one or more boronic ester bonds, the film having accessible hydroxyl groups at a surface of the film. An reversible adhesive, compr...
|
|
WO/2023/094899A1 |
Disclosed herein is a topical therapeutic composition and method for the palliative treatment of irritated or inflamed skin tissue. The therapeutic composition comprises olive oil and tea tree oil. The palliative treatment. of the invent...
|
|
WO/2023/091856A1 |
The present invention relates to curable compositions useful in the manufacture of absorbent films or absorbent film products. Methods of using and manufacturing the compositions also disclosed.
|
|
WO/2023/088415A1 |
An Andrias davidianus skin secretion hydrolysate, and a preparation method therefor and an application thereof The preparation method comprises: S1: mixing a disulfide bond reducing agent and a first solvent to obtain a second solvent; S...
|
|
WO/2023/090291A1 |
According to the present invention, rare-earth ferrite containing a rare-earth element, iron, and oxygen is used as an antiviral agent. Specifically, rare-earth ferrite containing a rare-earth element, iron, and oxygen is used as a main ...
|
|
WO/2023/091145A1 |
An improved dressing is presented which enables quicker wound closure and a lower anesthesia requirement, comprised of an improved prior-art skin-substitute. The improvements consist of variations in the thickness of the woven portion of...
|
